Treatment News : Only 4 ADAPs Provide Guidelines-Recommended Cardio Meds

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 31, 2011

Only 4 ADAPs Provide Guidelines-Recommended Cardio Meds

Only four AIDS Drug Assistance Programs (ADAPs) are providing medications to help manage four major cardiovascular disease (CVD) risk factors common among people living with HIV: type 2 diabetes, high blood pressure, elevated cholesterol and triglyceride levels and smoking. This is the finding of a survey published in the Journal of General Internal Medicine (JGIM) and reported by aidsmap.

While many ADAPs do provide access to many, if not all, of the available antiretrovirals (ARVs) for people living with HIV who qualify for assistance—about one third of HIV-positive people in the United States—coverage for medications needed to prevent or treat health complications related to, or exacerbated by, HIV infection is limited.

According to the JGIM analysis, only four state ADAPs—Massachusetts, New Jersey, New York and Pennsylvania—provided prescription drug coverage consistent with guidelines for all four cardiovascular risk factors. However, 68 percent of states and territories provided therapy that was at least partially consistent with guidance for one risk factor. No coverage was provided by 25 percent of ADAPs.

“In our systematic survey of ADAP formularies, we identified only four states that provided prescription drug coverage consistent with clinical practice guidelines for all four modifiable cardiovascular risk factors,” write the investigators.

According to aidsmap, the study authors believe that financial pressures and cost cutting could lead to some ADAPs restricting their access to non-HIV medications.

The researchers conclude that policymakers should address the “root causes” for the variations in coverage and “provide a comprehensive ADAP formulary informed by clinical guidelines.”

Search: AIDS Drug Assistance Program, ADAP, cardiovascular, CVD, prevention, diabetes, smoking, blood pressure, hypertension, cholesterol, triglycerides


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    Drew949
    South Orange County
    California


    usuallyhappy
    Palm Springs
    California


    usuallyhappy
    Palm Springs
    California


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been tested for hepatitis C?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.